SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0000950123-01-001188
Filing Date
2001-02-13
Accepted
2001-02-13 00:00:00
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D: NORTRAN PHARMACEUTICALS/RENNES y45430sc13d.txt SC 13D 8947
  Complete submission text file 0000950123-01-001188.txt   10755
Mailing Address 3650 WESBROCK MALL V6S 2L2 VANCOUVER BC
Business Address 3650 WESBROOK MALL V6S 2L2 VANCOUVER BC A1 6042225577
NORTRAN PHARMACEUTICALS INC (Subject) CIK: 0001036141 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1130
Type: SC 13D | Act: 34 | File No.: 005-60635 | Film No.: 1536505
SIC: 2834 Pharmaceutical Preparations

Mailing Address S.W. PORTE 3 POST OFFICE BOX 3580 ZURICH SWITERLAND
Business Address AEWLESTRUSSE 38 VODUZ LIECHTREUSTEIN FL
RENNES FOUNDATION (Filed by) CIK: 0001094515 (see all company filings)

Fiscal Year End: 1231